Capital Research Global Investors’s NuCana NCNA Stock Holding History

Capital Research Global Investors’s Portfolio NCNA Stock Details NCNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-916	Closed	-$22.9M	–	449
2021 Q1	$22.9M	Hold	916	–	–	0.01%	393
2020 Q4	$20.6M	Hold	916	–	–	0.01%	378
2020 Q3	$23.7M	Buy	916 +272	+42%	+$7.37M	0.01%	365
2020 Q2	$17.4M	Hold	644	–	–	0.01%	374
2020 Q1	$18.8M	Hold	644	–	–	0.01%	346
2019 Q4	$19.6M	Hold	644	–	–	0.01%	366
2019 Q3	$23.3M	Buy	644 +10	+2%	+$440K	0.01%	362
2019 Q2	$32.9M	Hold	634	–	–	0.01%	340
2019 Q1	$53.9M	Hold	634	–	–	0.02%	314
2018 Q4	$46M	Hold	634	–	–	0.02%	316
2018 Q3	$79M	Hold	634	–	–	0.02%	305
2018 Q2	$60.2M	Buy	634 +281	+80%	+$34.6M	0.02%	326
2018 Q1	$33.4M	Buy	353 +49	+16%	+$4.65M	0.01%	369
2017 Q4	$15.4M	Buy	304 +37	+14%	+$2.31M	﹤0.01%	395
2017 Q3	$24.5M	Buy	+267	New	+$23M	0.01%	368

Other funds holding NCNA

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors's NCNA Position: Q2 2021 in Review

Capital Research Global Investors sold out of NuCana (NCNA) in Q2 2021, closing a stake of 916 shares — an estimated $22.9M sold.

Capital Research Global Investors first reported a position in NCNA in Q3 2017 and held it in 15 quarters. The position peaked at $79M in Q3 2018. 27 funds tracked by Wall St. Rank hold NCNA as of Q2 2021.

Capital Research Global Investors reported no remaining NuCana position as of Q2 2021 after selling out during the quarter.
Capital Research Global Investors sold 916 NuCana shares in Q2 2021, an estimated $22.9M.
Capital Research Global Investors first reported a position in NuCana in Q3 2017 and held it in 15 quarters.
Capital Research Global Investors's NuCana position peaked at $79M in Q3 2018.
27 funds tracked by Wall St. Rank held NuCana as of Q2 2021.

Based on Capital Research Global Investors's 13F filing for Q2 2021, filed 16 Aug 2021.